Pharmacy Strategy

Top solutions to lower drug prices

September 06, 2017By Mari Edlin

PBMs partnering with pharmacies and drug makers may have a solution to nonadherence due to high pharma costs.

Trump declares Opioid ‘National Emergency’: 3 healthcare impacts

August 30, 2017By Karen Appold

Experts share how the declaration could affect how the opioid epidemic is managed.

Controversy surrounds Exondys 51 approval: What to know

August 04, 2017By Mari Edlin

New medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.

Brace for a barrage of biosimilars

August 02, 2017By Erin Bastick PharmD RPh

The next few years will see the healthcare industry bracing itself for new biosimilar products for a range of illnesses from oncology to rheumatoid arthritis.

Top 3 factors in biosimilar coverage

July 15, 2017By Tracey Walker

An Avalere study has interesting findings about payer acceptance of biosimilars.

Three reasons for nonadherence

July 14, 2017By Clay Rhodes BCPS BCGP PharmD MBA

Uncover the root causes of why patients become nonadherent and be better positioned to improve the lives of patients and reduce costs through improved health outcomes.

ICER, VA join to work on drug value, price negotiations

July 11, 2017By Tracey Walker

Analysts discuss how pharmacoeconomics will make a difference in treatment decisions.